Sign inJoin waitlistJoin the waitlist

Oscar Lahoud

Chief Medical Officer, NYU Langone Hospital - Brooklyn · NYU Grossman School of Medicine

Credentials: · · · ·

History

Hematology - Brooklyn Section · NYU Grossman School of Medicine
Present
NYU Grossman School of Medicine
Present

Bone Marrow Transplantation
Memorial Sloan Kettering Cancer Center
2016–2017
Hematology and Medical Oncology
Maimonides Medical Center
2013–2016
Internal Medicine
Maimonides Medical Center
2009–2012
University of Michigan Medical School
2005–2009

Research

Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma
Journal of Clinical Oncology · 2021 · 172 citations
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN…
JAMA Oncology · 2021 · 104 citations
Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial
The Lancet Haematology · 2021 · 86 citations

SG
Sergio Giralt
41 papers
Gunjan Shah
38 papers
HL
Heather Landau
38 papers
Michael Scordo
35 papers
DC
David Chung
33 papers
HH
Hani Hassoun
31 papers
SM
Sham Mailankody
30 papers
AL
Alexander Lesokhin
29 papers
NK
Neha Korde
29 papers
MH
Malin Hultcrantz
27 papers
Urvi Shah
26 papers · 3 as a fellow
Ola Landgren
21 papers

Clinical trials

Emapalumab Prophylaxis of Bispecific T-Cell Engagers (BiTEs) Associated CRS and ICANS
Principal investigator · Not yet recruiting · Phase 2
NYU Langone Health
2026–2029